Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Kowalski DM"'
Publikováno v:
European Journal of Cancer. 32:S25
Concentrations of CA 15-3 antigen were measured at diagnosis in the sera of 90 node-negative breast cancer women. CA 15-3 values correlated with the higher histological grade (p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rittmeyer, Achim, Barlesi, Fabrice, Waterkamp, Daniel, Park, Keunchil, Ciardiello, Fortunato, von Pawel, Joachim, Gadgeel, Shirish M, Hida, Toyoaki, Kowalski, Dariusz M, Dols, Manuel Cobo, Cortinovis, Diego L, Leach, Joseph, Polikoff, Jonathan, Barrios, Carlos, Kabbinavar, Fairooz, Frontera, Osvaldo Arén, De Marinis, Filippo, Turna, Hande, Lee, Jong-Seok, Ballinger, Marcus, Kowanetz, Marcin, He, Pei, Chen, Daniel S, Sandler, Alan, Gandara, David R, OAK Study Group
Publikováno v:
Lancet (London, England), vol 389, iss 10066
Summary Background Atezolizumab is a humanised antiprogrammed death-ligand 1 (PD-L1) monoclonal antibody that inhibits PD-L1 and programmed death-1 (PD-1) and PD-L1 and B7-1 interactions, reinvigorating anticancer immunity. We assessed its efficacy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42dc6dfde11f7da5a55f0efbbbb828a8
http://hdl.handle.net/11591/368087
http://hdl.handle.net/11591/368087
Autor:
Reck M; Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany. Electronic address: m.reck@lungenclinic.de., Dziadziuszko R; Faculty of Medicine, Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan., Kao S; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia., Hochmair M; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna North Hospital Klinik Floridsdorf, Vienna, Austria., Huemer F; Department of Respiratory Care, Ludwig Boltzmann Institute for Lung Health, Klinik Penzing, Vienna, Austria., de Castro G Jr; Clinical Oncology, Instituto de Cancer do Estado de São Paulo, Hospital Das Clínicas Da FMUSP, São Paulo, Brazil., Havel L; First Faculty of Medicine, Charles University, Thomayer Hospital, Prague, Czech Republic., Bernabé Caro R; Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain., Losonczy G; Faculty of Medicine, Semmelweis University, Budapest, Hungary., Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea., Kowalski DM; Department of Lung Cancer and Chest Tumours, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Andric Z; Department of Medical Oncology, Clinical Hospital Centre Bezanijska Kosa, Belgrade, Serbia., Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust and Division of Cancer Sciences, The University of Manchester, Manchester, UK., Veatch A; Northwest Medical Specialties, Puyallup, WA, USA., Gerstner G; Illinois Cancer Care, Peoria, IL, USA., Batus M; Medical Oncology, Rush University Medical Center, Chicago, IL, USA., Morris S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kaul M; Oncology Product Development Safety, Genentech Inc, South San Francisco, CA, USA., Cuchelkar V; Product Development Oncology-Hematology, Genentech, South San Francisco, CA, USA., Li H; Roche, Product Development China, Shanghai, China., Danner BJ; Genentech, South San Francisco, CA, USA., Nabet BY; Computational Sciences, Genentech, South San Francisco, CA, USA., Liu SV; Thoracic Oncology and Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Oct; Vol. 196, pp. 107924. Date of Electronic Publication: 2024 Aug 10.
Autor:
Piórek A; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Płużański A; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Knetki-Wróblewska M; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Winiarczyk K; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Tabor S; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Kowalski DM; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Krzakowski M; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Publikováno v:
Oncology reviews [Oncol Rev] 2024 Sep 18; Vol. 18, pp. 1451247. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).
Autor:
Piórek A; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Płużański A; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Wiśniewski P; Department of Pathology, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland., Tabor S; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Winiarczyk K; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Knetki-Wróblewska M; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Kowalski DM; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Krzakowski M; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Publikováno v:
Diseases (Basel, Switzerland) [Diseases] 2024 Aug 11; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 11.
Autor:
Kowalski DM; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Zaborowska-Szmit M; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Szmit S; Department of Cardio-Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland., Jaśkiewicz P; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Krzakowski M; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Publikováno v:
Translational lung cancer research [Transl Lung Cancer Res] 2024 Jun 30; Vol. 13 (6), pp. 1426-1431. Date of Electronic Publication: 2024 Jun 25.